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Department of Physiology and Biophysics, State University of New York, Buffalo, New YorkABSTRACT The neuromuscular acetylcholine receptor (AChR) is an allosteric protein that alternatively adopts inactive versus
active conformations (R4R*). The R* shape has a higher agonist afﬁnity and ionic conductance than R. To understand how
agonists trigger this gating isomerization, we examined single-channel currents from adult mouse muscle AChRs that isomerize
normally without agonists but have only a single site able to use agonist binding energy to motivate gating. We estimated the
monoliganded gating equilibrium constant E1 and the energy change associated with the R versus R* change in afﬁnity for
agonists. AChRs with only one operational binding site gave rise to a single population of currents, indicating that the two trans-
mitter binding sites have approximately the same afﬁnity for the transmitter ACh. The results indicated that E1z 4.3  103 with
ACh, andz1.7  104 with the partial-agonist choline. From these values and the diliganded gating equilibrium constants, we
estimate that the unliganded AChR gating constant is E0z 6.5 107. Gating changes the stability of the ligand-protein complex
by ~5.2 kcal/mol for ACh and ~3.3 kcal/mol for choline.INTRODUCTIONNicotinic acetylcholine receptors (AChRs) are ligand-gated
ion channels that trigger fast transmission at the vertebrate
neuromuscular synapse (1–3). Each AChR has five subunits
(a2bd3, in adult muscle) and two transmitter binding sites
(one in the extracellular domain of each a subunit near the
adjacent d or 3 subunit). Acetylcholine (ACh) released
from the nerve terminal occupies these sites to initiate
a global, gating conformational change in the protein that
leads to the depolarization of the muscle membrane.
AChRs are able to isomerize between nonconducting
and conducting shapes (R4R*) both with and without
agonists present at the binding sites, by approximately the
same sequence of intramolecular events (4,5). In addition
to having a higher ionic conductance, R* also has a higher
affinity for agonists, and it is this difference in ligand-
binding energy that causes the gating equilibrium constant
to increase substantially when the binding sites are occupied
by, for example, the transmitter ACh. To understand
how exogenous molecules motivate gating, it is of value to
quantify the R versus R* difference in binding energy
experienced by agonists at each site. Without an external
energy source, the ratio of gating equilibrium constants
with one versus no bound agonist molecule (E1/E0) is
equal to the ratio of agonist equilibrium dissociation con-
stants of that binding site in R versus R* (Kd/Jd) (1). Here,
we estimate the E1/E0 ratio, and hence the change in binding
energy, by studying AChRs that have only one site able to
use ligands to set in motion the gating conformational
change.
It is still not known with certainty whether the two AChR
transmitter binding sites have the same affinity for ACh. The
R affinities of these two sites for the antagonist curare (6–8)Submitted October 29, 2009, and accepted for publication January 14, 2010.
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0006-3495/10/05/1840/7 $2.00and some protein toxins (9–11) differ substantially. The loca-
tion of the binding sites near subunit interfaces provides
a structural rationale for such different affinities for these
relatively large ligands. Also, on theoretical grounds it has
been proposed that synaptic performance is better optimized
by having distinct binding-site affinities for the transmitter
(12). However, the experimental evidence regarding the
affinities for ACh at the two binding sites is equivocal.
Some single-channel kinetic studies have reported distinct
ACh affinities at the two sites (13–15), whereas others
have found no such difference (16–18). It has been suggested
that the omission of a short-lived nonconducting state
(whose lifetime is independent of the agonist concentration
(19)) from the single-channel modeling studies leads to the
incorrect designation of one binding site as having a very
low affinity for the agonist (18). One of our objectives in
this study was to resolve the issue of transmitter binding-
site equality more definitively by making direct, single-
channel measurements of the functional properties of AChRs
with only a single site capable of using agonist-binding
energy for gating.
These measurements offered a new method for estimating
E0 and the energy made available for gating by the change in
the affinity of the protein for the agonist. By measuring E1
experimentally (for each site), and with prior knowledge
of the diliganded equilibrium constant E2, we were able
to calculate the affinity ratios for the two binding sites, and
hence E0, for adult mouse neuromuscular AChRs. The
results show that the two binding sites have approximately
the same affinity for ACh in both R and R*, and that
R/R* gating decreases the equilibrium dissociation
constant for ACh or choline by a factor of ~6600 or 270
(5.2 or 3.3 kcal/mol). The magnitudes of these energies
provide a foundation for understanding how ligands coax
proteins to change shape.doi: 10.1016/j.bpj.2010.01.025
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Mutations of mouse AChR subunit cDNAs were made by using the Quick-
Change site-directed mutagenesis kit (Stratagene, La Jolla, CA), and verified
by nucleotide sequencing. Human embryonic kidney fibroblast cells (HEK
293) were transiently transfected using calcium phosphate precipitation
method. HEK cells were treated with 3.5–5.5 mg DNA per 35-mm culture
dish in the ratio of 2:1:1:1 (a:b:d:3) for ~16 h. Most electrophysiological
recordings were made ~24 h later. For hybrid experiments, HEK cells were
transfected in a cDNA ratio of 1:1:1:1:1. Recordings were performed in
a cell-attached patch configuration at 23C. Agonist was dissolved in the
pipette solution (Dulbecco’s phosphate-buffered saline) containing (in mM)
137 NaCl, 0.9 CaCl2, 2.7 KCl, 1.5 KH2PO4, 0.5 MgCl2, and 8.1 Na2HPO4
(pH 7.3). The bath solution was identical to the pipette solution. The pipettes
were made from borosilicate capillaries and coated with Sylgard (Dow Corn-
ing, Midland, MI). The average pipette resistance was ~10 MU. The pipette
potential was held at þ70 mV, which corresponds to a membrane potential
of ~100 mV. Single-channel currents were recorded using a PC-505 ampli-
fier (Warner Instruments, Hamden, CT). For most experiments, the currents
were low-pass-filtered at 20 kHz and digitized at a sampling frequency of
50 kHz using a SCB-68 acquisition board (National Instruments, Austin,
TX). For the cross-concentration experiments, the currents were sampled at
100 kHz. All recording and analyses were done with the use of QUB software
(http://www.qub.buffalo.edu).
For rate constant analysis, clusters of individual-channel activity were
selected so that the flanking, nonconducting intervals wereR50 ms. Clus-
ters were idealized into noise-free intervals after they were filtered digitally
(12 kHz) by using the segmental k-means algorithm (20) with a two-state,
C(losed)4O(pen) model (starting rate ¼ 10 s1). The opening and closing
rate constants were estimated from the idealized interval durations by using
a maximum-interval likelihood algorithm (21) after imposing a dead time of
50 ms. Usually, the rate constants were estimated by using a two-state model
because the log likelihood of the fit did not increase after additional C or O
states were added. In some patches, a second nonconducting state was con-
nected to the open state to accommodate a relatively rare and short-lived
state associated with desensitization (19).
The apparent values of the monoliganded forward (f1) and backward (b1)
isomerization rate constants underestimate the true values (Table 1). First,TABLE 1 Gating rate and equilibrium constants for un- and
monoliganded AChRs
DYS is the AChR construct a(D97AþY127FþS269I), which increases E0
by a factor of ~106; *, from Purohit and Auerbach (5); n, number of patches;
uncorrected rate constants: f, forward R/R* (mean5 SE for n patches); b,
backward R)R*. E0, unliganded equilibrium constant; E1, monoliganded
equilibrium constant. E1 was calculated after correction for subsaturation of
the binding site, channel block by the agonist, and the change in E0 caused
by the background mutations (see Materials and Methods). The average
value for all constructs with ACh is E1 ¼ 4.3 5 0.4  103 (mean 5
SE). The diliganded equilibrium constants (E2) for ACh and choline are
28 (31) and 4.6  102 (28). The ratio E2/E1 (which is equal to the Kd/Jd
affinity ratio) for these agonists is 6600 and 270. E1 divided by this ratio
is E0, 6.6  107 and 6.3  107, respectively.even at high agonist concentrations, the (single) wild-type (wt) binding
site is not completely saturated, and the apparent intracluster, closed-channel
inverse lifetime is less than f1 by a factor F¼ ([A]/Kd)/(1þ([A]/Kd)), where A
is the agonist and Kd is the R equilibrium dissociation constant (~140 mM
for ACh, ~4 mM for choline in wt AChRs). We calculate that F z 0.78
at 500 mM ACh and 0.83 at 20 mM choline. Second, the apparent b1 under-
estimates the true backward isomerization rate constant because unresolved,
fast channel-block by the agonist prolongs the apparent R* lifetime. For
this correction, we used the ratio of the current amplitude at 10 mM ACh,
where there is essentially no channel block (i0; ~7 pA) to the current
amplitude at 500 mM ACh (or 20 mM choline), where such a block pertains
(iB). We made the first-order approximation that the blocking agonist
molecule only dissociates from the R* conformation of the pore, in
which case the block prolongs openings in proportion to the i0/iB ratio:
b1
corrected ¼ b1apparent(i0/iB) (22).
In some experiments, monoliganded clusters of openings were measured
in AChRs with a gain-of-function background mutation (aS269I, aD97F, or
aP272A). We corrected for the background perturbation by assuming that
the fold changes in f1 and b1 caused by the mutations were the same as previ-
ously measured for diliganded receptors; that is, we assumed that the back-
ground mutation increased E0 by 91-fold (aS269I (23)), 31-fold (aD97F
(24)), or 237-fold (aP272A (25)). The fact that these corrections all led to
similar E0 estimates supports the hypothesis that these mutations only per-
turb E0 and do not significantly alter the isomerization conformational path-
way(s) or the agonist affinity ratio (5) (Table 1).
We also made a small correction for the effects of the aW149M and
aW149L binding-site mutations on E0. These double mutations (one at
each of the two binding sites) decreased unliganded gating (E0) by 1.5-fold
and 13.8-fold, respectively. As a first approximation, we assumed that this
effect was equally divided between the two binding sites, and therefore multi-
plied the apparent E1 values (after the above corrections for saturation, block,
and background) by the square root of the corresponding fold change in E0.
AChRs that have aW149M or aW149L mutations at both binding sites
can be activated by very high ACh concentrations, which indicates that
this ligand is not acting as an inverse agonist at the mutated binding site
(the R/R* affinity ratio is >1; P. Purohit and A. Auerbach, unpublished
observations). Preliminary results for double-mutant aW149M AChRs
show Kd > 10 mM and E2 z 3  103. We estimate that at 500 mM
ACh, >95% of the hybrid AChRs are monoliganded. These constructs
have low activity in 500 mM ACh (Fig. 1 B) because they have both
a low affinity and a low affinity ratio for ACh.
The association (kþ) and dissociation (k) rate constants for ACh binding
were estimated from intracluster interval durations obtained at different ACh
concentrations. The interval durations at all concentrations were fitted
together by using a kinetic model (C4AC4AO, where A is ACh) that
had four rate constants: kþ, k, f1 (AC/AO) and b1 (AC)AO). With the
a149(WþL)þaS269I construct, in the fit all four rate constants were free
parameters. With the a149(WþM)þaS269I construct, f1 was fixed at 520 s1.RESULTS
Our experimental approach was to express AChRs that isom-
erize normally (i.e., have an E0 value similar to that of wt
AChRs) but are able to utilize agonist-binding energy at
only one of the two transmitter binding sites. We would
not have been able to achieve that goal by using site-specific
antagonists, because the affinity ratios for such ligands are
unknown.
Each a subunit has a conserved binding-site Trp residue
(aW149) that is an important determinant of ACh affinity
(26,27). Fig. 1 shows the effects of mutating this residue,
in both the absence and presence of ACh, on two different

















FIGURE 1 aW149 mutations allow spontaneous gating
but eliminate gating by 500 mM ACh. (A) Spontaneous
activity (in the absence of agonists) of AChRs with three
gain-of-function background mutations that greatly
increase the unliganded gating equilibrium constant,
E0 (aD97AþaY127FþaS269I). Top: Single-channel
currents from the background construct alone. Each cluster
represents the R4R* activity of a single, unliganded
AChR (conducting is down); long gaps between clusters
are periods when all AChRs in the patch are desensitized;
bottom trace is expanded view of marked currents. Middle
and bottom: Spontaneous currents after adding a binding-
site (aW149) mutation (Met or Leu, respectively). These
mutations have only a modest effect on E0 (Table 1). (B)
Activity of AChRs exposed to 500 mM ACh (wt back-
ground, which shows very little spontaneous gating).
Top: The open probability within clusters is high because
the AChRs without any aW149 mutations are able to
bind and use energy from ACh at both transmitter binding
sites. Middle and bottom: The binding-site (aW149) muta-
tions reduce the frequency of openings because they are
unable to bind ACh or use energy from the agonist affinity
change to trigger gating. Left and right calibrations are for
low- and high-resolution views throughout.
1842 Jha and Auerbachindividual AChRs with multiple background mutations
(which together increase E0 by a factor of ~10
6) open sponta-
neously in clusters, each of which reflects the activity of an
individual AChR (5). Fig. 1 A and Table 1 show that mutating
aW149 (in both a subunits) to Met or Leu has only a modest
effect on the apparent unliganded equilibrium constant. This
result indicates that the aW149M and aW149L constructs
are able to isomerize spontaneously between R and R*
conformations much like wt AChRs.
Fig. 1 B shows that on a wt background (which has a very
low probability of opening spontaneously), either of these
mutations greatly reduces the ability of AChRs to be activated
by a 500 mM ACh. Because the E0 values of the mutants are
only slightly different from that of the wt, the failure of
aW149M and aW149L AChRs to generate clusters in the
presence of ACh indicates that at this ACh concentration
the mutant binding sites are unable to utilize ligand-binding
energy to significantly increase the isomerization equilibrium
constant (see Materials and Methods).
The key experiment was to coexpress both aW149M and
aW149 (wt) a subunits along with wt b, d, and 3 subunits.
This protocol is expected to lead to four different AChR pop-
ulations. Some of the expressed AChRs should have W-W at
position a149 at the two binding sites, and some should have
M-M. There should also be two hybrid populations, with
W-M or M-W at the two binding sites. Because the
double-mutant aW149M mutation has only a small effect
on E0 (a ~1.5-fold reduction), and because this mutation
essentially eliminates activation by 500 mM ACh, both
hybrid constructs should be able to isomerize normally but
with only one binding site capable of using energy from
the transmitter molecule. Thus, the single-channel currents
from the hybrid clusters activated by 500 mM ACh shouldBiophysical Journal 98(9) 1840–1846exclusively reflect the activity of AChRs activated by just
one agonist molecule.
Fig. 2 A shows clusters of openings from a aW149M
hybrid experiment, using an otherwise wt background. At
500 mM ACh, high open-probability clusters generated by
doubly liganded wt (W-W) AChRs are apparent, as are occa-
sional, isolated openings arising from the inefficient, double-
mutant (M-M) constructs. In addition, a new population of
clusters was observed, which we interpret as arising from
the activity of the monoliganded, hybrid constructs W-M
and M-W. After several corrections to the rate constants
(see Materials and Methods), we estimate from this construct
that for wt AChRs, E1
ACh ¼ 3.7  103 (Table 1).
With the wt background, the hybrid clusters were of long
duration and had a low open probability and were therefore
difficult to isolate and quantify. We therefore added a gain-
of-function background mutation to both the aW149 and
aW149-mutant a subunits. aS269I (in the transmembrane,
M2 helix) increases E0 by 91-fold, does not influence agonist
binding and has equal and independent effects on the gating
equilibrium constant in the two a subunits (23,28,29).
Fig. 2 B shows example clusters from experiments using
this background mutation. Again, clusters from diliganded,
W-W AChRs and isolated openings from broken, M-M
AChRs were apparent, along with clusters of openings
arising from hybrid AChRs. In all patches, only a single
hybrid population was apparent (Fig. 2 C), with both the con-
ducting and nonconducting intervals within the clusters
having single-exponential distributions (Fig. 2 D). After
correction, from this construct we estimate that in wt AChRs,
E1
ACh ¼ 3.3  103 (Table 1).
We also examined monoliganded clusters from aW149M





























































A FIGURE 2 Gating activity of monoliganded (hybrid)
AChRs activated by ACh. (A) Activity of hybrid AChRs
(wt background) exposed to 500 mM ACh. The AChRs
had a combination of aW149 and aW149M residues at
the two transmitter binding sites. The bottom two traces
are marked openings at an expanded scale. Diliganded
AChRs with two aW149 residues (wt; W-W) can use
ACh binding energy to open efficiently and therefore
produce high open-probability clusters. Monoliganded
(hybrid) AChRs with one aW149 and one aW149M
(hybrid; W-M and M-W) can use ACh binding energy at
only one transmitter binding site and therefore produce
lower open-probability clusters. (B) Activity of fully li-
ganded, hybrid AChRs with the gain-of-function back-
ground mutation aS269I (Table 1). The AChRs had
a combination of aW149 and aW149M residues at the
two transmitter binding sites. In the low-resolution view,
the sporadic, isolated openings reflect M-M AChRs that
cannot utilize ACh binding energy. Marked clusters
from wt and hybrid AChRs are shown below. (C) Cluster
population analysis (aS269I background). Left: Both
diliganded (W-W) high open-probability clusters (0.93;
solid circles) and monoliganded (W-M and M-W) low
open-probability clusters (0.19; open circles) are apparent
in a single patch. Right: The monoliganded population, fitted by a single Gaussian. There is only one monoliganded population. (D) The conducting and
nonconducting intervals within the monoliganded clusters are each fitted by a single exponential.
Monoliganded Gating 1843(see Fig. S1 in the Supporting Material). The results were
similar to those obtained with the wt and aS269I
backgrounds (Table 1). Fig. S1 also shows the results of
experiments using the aW149L mutation and the aS269I
background. Again, in all patches only a single population
of hybrid clusters was apparent. The E1 estimates for all of
the AChR constructs were within a factor of 1.6. This supports
the hypothesis that the background mutations act indepen-







































αW149L hybridcombined, we estimate that for wt AChRs, E1
ACh ¼ 4.3 
103 (Table 1).
To test whether the single population of clusters reflected
AChRs having either one functional a3 or one functional ad
site, we coexpressed d subunits having the mutation dW57A
(Fig. S2). This mutation, which is on the minus side of the ad
transmitter binding site, reduces the R affinity of only that
site by ~28-fold (30), so at 500 mM ACh this site would
not be saturated by the agonist (14% occupancy versusration (ms)
1 2 3
FIGURE 3 ACh binding parameters for monoliganded
AChRs. (A) Results for aW149M hybrid AChRs (back-
ground, aS269I) activated by various [ACh]. For each
panel: (left) example hybrid clusters; (right) intracluster,
nonconducting interval histograms and probability density
functions (solid line) computed from global model-fitting
across concentrations (see Materials and Methods). The
estimated rate constants (5SD) were as follows: associa-
tion 153 5 53 mM1s1 and dissociation 19,969 5
9410 s1 (equilibrium dissociation constant: 131 mM;
number of intervals: 5198). The published estimates for
the association and dissociation rate constants for wt
AChRs, assuming equal binding sites, are 167 mM1 s1
and 24,745 s1, respectively (18). (B) Results for
aW149L hybrid AChRs (background, aS269I) activated
by various [ACh]. The estimated rate constants were as
follows: association, 126 5 32 mM1s1; dissociation,
18,099 5 4609 s1 (equilibrium dissociation constant:
144 mM; number of intervals: 10,218).





































FIGURE 4 Gating activity of monoliganded (hybrid) AChRs activated by
choline. (A) Activity of fully liganded and hybrid AChRs with the gain-of-
function background mutation aP272A and activated by choline (Table 1).
The AChRs had a combination of aW149 and aW149M residues at the two
transmitter binding sites. Marked clusters from wt and hybrid AChRs are
shown below. (B) Cluster population analysis. Left: Both diliganded
(W-W) high open-probability clusters (0.80; solid circles) and monoli-
1844 Jha and Auerbach78% occupancy for the wt site; see Materials and Methods).
Two populations of monoliganded clusters were apparent in
this experiment: one having approximately the same open
probability as without the dW57A mutation, and one with
a lower open probability. We conclude that the single popu-
lation of hybrid clusters observed without the dW57A muta-
tion arises from monoliganded AChRs, with both single-a3
and -ad sites contributing. This experiment also shows that
the hybrid AChRs contained both d and 3 subunits.
We next determined for hybrid clusters the ACh associa-
tion (kþ) and dissociation (k) rate constants and their ratio,
the equilibrium dissociation constant (Kd ¼ k/kþ). Fig. 3, A
and B, show the results of fitting intracluster current interval
durations from W/M and W/L hybrid populations obtained
over a range of ACh concentrations. The estimated rate
constants were as follows: kþ ¼ 153 mM1s1, k ¼
19,969 s1, and Kd ¼ 131 mM (M hybrid); and
kþ¼ 126 mM1s1, k¼ 18,099 s1, and Kd ¼ 144 mM
(L hybrid). These rate and equilibrium constants are similar
to each other and essentially the same as those estimated
from fitting wt AChRs assuming equal and independent
binding sites: kþ ¼ 167 mM1 s1, k ¼ 24,745 s1, and
Kd ¼ 148 mM (16,18).
We repeated the hybrid experiments using choline as the
agonist. Fig. 4 shows monoliganded clusters from
aW149M hybrid AChRs expressed on the background
P272A (a mutation that increases E0 by 237-fold (25)).
With this partial agonist, only one hybrid population was
apparent. We estimate that for wt AChRs, E1
choline ¼
1.7  104 (Table 1).
ganded (W-M and M-W) low open-probability clusters (0.07; open circles)
are apparent in a single patch. Right: The monoliganded population, fitted by
a single Gaussian. There is only one population of monoliganded AChRs.DISCUSSION
In the hybrid experiments, we observed only a single popula-
tion of clusters arising from monoliganded AChRs (Figs. 2 C
and 4 B). The ACh association and dissociation rate constants
for this population are the same as for wt AChRs assuming
two equal and independent transmitter binding sites (Fig. 3).
These results indicate that the two adult mouse neuromuscular
AChR transmitter binding sites are approximately the same
with regard to ACh binding. The transmitter binding sites
are located near subunit interfaces, but there is no indication
that this structural fact has a significant effect on the binding
function of AChRs at the mouse neuromuscular synapse.
We estimate that for each transmitter binding site, the R
equilibrium dissociation constant for ACh is ~140 mM, which
is the ratio of the dissociation rate constant (~20,000 s1) and
the association rate constant (~1.4  108 M1s1).
To estimate the monoliganded gating equilibrium constant
(E1), we made several corrections to the apparent rate
constants (see Materials and Methods, and Table 1). With
these adjustments we estimate that the wt, monoliganded
equilibrium gating equilibrium constants (100 mV
membrane potential, 23C) are E1
ACh z 4.3  103 and
E1
choline z 1.7  104.Biophysical Journal 98(9) 1840–1846Estimates of the diliganded equilibrium constants (E2) for
these two agonists for adult mouse AChRs are available:
E2
ACh ¼ 28 (31) and E2choline ¼ 4.6  102 (28). Because
the energy available from agonist binding (the Kd/Jd affinity
ratio) for the two sites is identical, E2/E1 ¼ E1/E0. Hence,
E0 ¼ E12/E2. Of significance, the E0 values calculated by
using this relationship were essentially the same for ACh
and choline. The average for all backgrounds and agonists
was E0z 6.5  107 (Table 1).
E0 was previously estimated by a completely different
method that used exclusively unliganded AChRs (5). By
measuring spontaneous gating in constructs that had various
combinations of background mutations that each increased
E2 to known extents, and by assuming that the mutations
were independent and had no effect on the affinity ratio,
we estimated an average value: E0 z 1.2  107. Another
E0 estimate can be gained from these same data by extrapo-
lating to the condition of no change in E2, in which case
E0 z 7.7  107. The E0 estimate obtained from hybrid
analyses falls within these limits, but it, too, is imprecise.
The experimental E1
ACh values vary by 1.6-fold (Table 1),
Monoliganded Gating 1845and published estimates of E2
ACh vary to a similar degree.
We think that E0z 6.5 107 is currently the best estimate,
but more experiments will likely increase the precision to
which we know the magnitude of this fundamental gating
equilibrium constant.
It is extremely valuable to have an accurate estimate of E0
because we can use it to calculate all of the rate and equilib-
rium constants for AChR activation (Fig. S3). At each
binding site, we estimate that the R/R* affinity ratio
(¼E2/E1) is ~6600 for ACh and ~270 for choline. These
values translate to a per-site difference in agonist-binding
energy (R* versus R) of ~5.2 kcal/mol for ACh and
~3.3 kcal/mol for choline. For ACh, the equilibrium
dissociation constant from R z 140 mM, so that from
R* z 20 nM. The ACh dissociation rate constant from R*
is ~12 s1 (32), so the corresponding association rate
constant is ~5  108 M1s1. Gating hardly alters the rate
constant at which ACh enters the transmitter binding sites.
It will be worthwhile to explore the extents to which
binding and gating parameters are the same or different for
other receptor channels and for different agonists. It will
also be interesting to learn the atomic forces that gene-
rate the net binding energies for different ligands (e.g., the
~1.9 kcal/mol difference between ACh and choline) or
different AChRs with binding-site mutations. Finally, we
would like to know whether the conformational pathway
of the R4R* isomerization is the same for AChRs asym-
metrically activated by only a single agonist as it appears
to be for un- and diliganded AChRs.SUPPORTING MATERIAL
Three figures are available at http://www.biophysj.org/biophysj/
supplemental/S0006-3495(10)00158-X.
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